Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum.

Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum.
复制标题

DOI:
10.1007/s11239-022-02643-3
复制
发表时间:
2022-08
影响因子:
4
通讯作者:
Minichiello, Tracy
Minichiello, Tracy
中科院分区:
医学4区
文献类型:
--
作者:
Barnes, Geoffrey D.;Burnett, Allison;Allen, Arthur;Ansell, Jack;Blumenstein, Marilyn;Clark, Nathan P.;Crowther, Mark;Dager, William E.;Deitelzweig, Steven B.;Ellsworth, Stacy;Garcia, David;Kaatz, Scott;Raffini, Leslie;Rajasekhar, Anita;Van Beek, Andrea;Minichiello, Tracy

文献摘要

参考文献

被引文献

相似文献

血栓栓塞是COVID-19感染对住院患者造成的常见和致命后果。基于COVID-19大流行前的临床证据和早期观察报告,专家共识和指南文件强烈鼓励因COVID-19感染住院的患者使用预防性抗凝治疗。最近,多项临床试验和更大规模的观察性研究为定制COVID-19患者的血栓预防方法提供了证据。本文件提供了北美领先的抗凝治疗提供者组织抗凝论坛(Anticoagulation Forum)关于COVID-19患者使用抗凝治疗的最新指南。我们讨论了门诊、院内和院后血栓预防策略,并为考虑接种COVID-19疫苗的血栓性疾病患者提供指导。在线版本包含补充材料,可通过10.1007/s11239-022-02643-3获得。
Thromboembolism is a common and deadly consequence of COVID-19 infection for hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and early observational reports, expert consensus and guidance documents have strongly encouraged the use of prophylactic anticoagulation for patients hospitalized for COVID-19 infection. More recently, multiple clinical trials and larger observational studies have provided evidence for tailoring the approach to thromboprophylaxis for patients with COVID-19. This document provides updated guidance for the use of anticoagulant therapies in patients with COVID-19 from the Anticoagulation Forum, the leading North American organization of anticoagulation providers. We discuss ambulatory, in-hospital, and post-hospital thromboprophylaxis strategies as well as provide guidance for patients with thrombotic conditions who are considering COVID-19 vaccination. The online version contains supplementary material available at 10.1007/s11239-022-02643-3.
DOI: 10.1182/blood.2020010529
发表时间: 2021-05-20
期刊: Blood
影响因子: 20.3
作者:
Giannis D;Allen SL;Tsang J;Flint S;Pinhasov T;Williams S;Tan G;Thakur R;Leung C;Snyder M;Bhatia C;Garrett D;Cotte C;Isaacs S;Gugerty E;Davidson A;Marder GS;Schnitzer A;Goldberg B;McGinn T;Davidson KW;Barish MA;Qiu M;Zhang M;Goldin M;Matsagkas M;Arnaoutoglou E;Spyropoulos AC
通讯作者: Spyropoulos AC
DOI: 10.1182/blood.2020008086
发表时间: 2020-09-10
期刊: BLOOD
影响因子: 20.3
作者:
Roberts, Lara N.;Whyte, Martin B.;Arya, Roopen
通讯作者: Arya, Roopen
DOI: 10.1182/bloodadvances.2018024802
发表时间: 2018-11-27
期刊: BLOOD ADVANCES
影响因子: 7.5
作者:
Bates, Shannon M.;Rajasekhar, Anita;Rochwerg, Bram
通讯作者: Rochwerg, Bram
DOI: 10.1182/bloodadvances.2020003083
发表时间: 2020-11-10
期刊: Blood advances
影响因子: 7.5
作者:
Hill JB;Garcia D;Crowther M;Savage B;Peress S;Chang K;Deitelzweig S
通讯作者: Deitelzweig S
DOI: 10.1002/rth2.12529
发表时间: 2021-06
影响因子: 4.6
作者:
Makris M;Pavord S;Lester W;Scully M;Hunt B
通讯作者: Hunt B